Small molecule therapeutics targeting F-box proteins in cancer

Stockwell, 2011, Outsmarting Cancer. A biologist talks about what makes disease-causing proteins so difficult to target with drugs, Sci. Am., 305, 20 Hershko, 1998, The ubiquitin system, Ann. Rev. Biochem., 67, 425, 10.1146/annurev.biochem.67.1.425 Komander, 2012, The ubiquitin code, Ann. Rev. Biochem., 81, 203, 10.1146/annurev-biochem-060310-170328 Deshaies, 2009, RING domain E3 ubiquitin ligases, Ann. Rev. Biochem., 78, 399, 10.1146/annurev.biochem.78.101807.093809 Petroski, 2005, Function and regulation of cullin–RING ubiquitin ligases, Nat. Rev. Mol. Cell Biol., 6, 9, 10.1038/nrm1547 Feldman, 1997, A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p, Cell, 91, 221, 10.1016/S0092-8674(00)80404-3 Skowyra, 1997, F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin–ligase complex, Cell, 91, 209, 10.1016/S0092-8674(00)80403-1 Cardozo, 2004, The SCF ubiquitin ligase: insights into a molecular machine, Nat. Rev. Mol. Cell Biol., 5, 739, 10.1038/nrm1471 Bai, 1996, SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box, Cell, 86, 263, 10.1016/S0092-8674(00)80098-7 Cenciarelli, 1999, Identification of a family of human F-box proteins, Curr. Biol.: CB, 9, 1177, 10.1016/S0960-9822(00)80020-2 Winston, 1999, A family of mammalian F-box proteins, Curr. Biol.: CB, 9, 1180, 10.1016/S0960-9822(00)80021-4 Jin, 2004, Systematic analysis and nomenclature of mammalian F-box proteins, Genes Dev., 18, 2573, 10.1101/gad.1255304 Ravid, 2008, Diversity of degradation signals in the ubiquitin-proteasome system, Nat. Rev. Mol. Cell Biol., 9, 679, 10.1038/nrm2468 Lau, 2012, The Fbw7 and betaTRCP E3 ubiquitin ligases and their roles in tumorigenesis, Front. Biosci., 17, 2197, 10.2741/4045 Frescas, 2008, Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer, Nat. Rev. Cancer, 8, 438, 10.1038/nrc2396 Nash, 2001, Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication, Nature, 414, 514, 10.1038/35107009 Liu, 2002, Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism, Cell, 108, 837, 10.1016/S0092-8674(02)00685-2 Welcker, 2003, Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation, Mol. Cell, 12, 381, 10.1016/S1097-2765(03)00287-9 Wei, 2005, The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase, Cancer Cell, 8, 25, 10.1016/j.ccr.2005.06.005 Abbas, 2013, CRL1-FBXO11 promotes Cdt2 ubiquitylation and degradation and regulates Pr-Set7/Set8-mediated cellular migration, Mol. Cell, 49, 1147, 10.1016/j.molcel.2013.02.003 Rossi, 2013, Regulation of the CRL4(Cdt2) ubiquitin ligase and cell-cycle exit by the SCF(Fbxo11) ubiquitin ligase, Mol. Cell, 49, 1159, 10.1016/j.molcel.2013.02.004 Skaar, 2013, Mechanisms and function of substrate recruitment by F-box proteins, Nat. Rev. Mol. Cell Biol., 14, 369, 10.1038/nrm3582 D’Angiolella, 2010, SCF(Cyclin F) controls centrosome homeostasis and mitotic fidelity through CP110 degradation, Nature, 466, 138, 10.1038/nature09140 Chen, 2011, Calmodulin antagonizes a calcium-activated SCF ubiquitin E3 ligase subunit, FBXL2, to regulate surfactant homeostasis, Mol. Cell. Biol., 31, 1905, 10.1128/MCB.00723-10 Chen, 2012, F-box protein FBXL2 exerts human lung tumor suppressor-like activity by ubiquitin-mediated degradation of cyclin D3 resulting in cell cycle arrest, Oncogene, 31, 2566, 10.1038/onc.2011.432 Chen, 2012, F-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferation, Blood, 119, 3132, 10.1182/blood-2011-06-358911 D’Angiolella, 2012, Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair, Cell, 149, 1023, 10.1016/j.cell.2012.03.043 Chen, 2013, A combinatorial F box protein directed pathway controls TRAF adaptor stability to regulate inflammation, Nat. Immunol., 14, 470, 10.1038/ni.2565 Liu, 2015, F-box protein Fbxl18 mediates polyubiquitylation and proteasomal degradation of the pro-apoptotic SCF subunit Fbxl7, Cell Death Dis., 6, e1630, 10.1038/cddis.2014.585 Richardson, 2003, A phase 2 study of bortezomib in relapsed, refractory myeloma, N. Engl. J. Med., 348, 2609, 10.1056/NEJMoa030288 Richardson, 2006, Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib, J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol., 24, 3113, 10.1200/JCO.2005.04.7779 Kouroukis, 2014, Bortezomib in multiple myeloma: systematic review and clinical considerations, Curr. Oncol., 21, e573, 10.3747/co.21.1798 Xie, 2013, Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer, J. Genet. Genom. – Yi chuan xue bao, 40, 97, 10.1016/j.jgg.2013.02.001 Zhao, 2013, Cullin–RING Ligases as attractive anti-cancer targets, Curr. Pharm. Des., 19, 3215, 10.2174/13816128113199990300 Weathington, 2014, Emerging therapies targeting the ubiquitin proteasome system in cancer, J. Clin. Invest., 124, 6, 10.1172/JCI71602 Skaar, 2014, SCF ubiquitin ligase-targeted therapies, Nat. Rev. Drug Discov., 13, 889, 10.1038/nrd4432 Wang, 2014, Roles of F-box proteins in cancer, Nat. Rev. Cancer, 14, 233, 10.1038/nrc3700 Liu, 2015, Targeting the ubiquitin pathway for cancer treatment, Biochim. Biophys. Acta, 1855, 50 Yu, 1998, Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins, Proc. Natl. Acad. Sci. U.S.A., 95, 11324, 10.1073/pnas.95.19.11324 Tsvetkov, 1999, p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27, Curr. Biol.: CB, 9, 661, 10.1016/S0960-9822(99)80290-5 Sutterluty, 1999, p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells, Nat. Cell Biol., 1, 207, 10.1038/12027 Carrano, 1999, SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27, Nat. Cell Biol., 1, 193, 10.1038/12013 Ganoth, 2001, The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27, Nat. Cell Biol., 3, 321, 10.1038/35060126 Spruck, 2001, A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1, Mol. Cell, 7, 639, 10.1016/S1097-2765(01)00210-6 Nakayama, 2004, Skp2-mediated degradation of p27 regulates progression into mitosis, Dev. Cell, 6, 661, 10.1016/S1534-5807(04)00131-5 Kossatz, 2004, Skp2-dependent degradation of p27kip1 is essential for cell cycle progression, Genes Dev., 18, 2602, 10.1101/gad.321004 Chan, 2013, Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression, Cell, 154, 556, 10.1016/j.cell.2013.06.048 Chan, 2012, The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis, Cell, 149, 1098, 10.1016/j.cell.2012.02.065 Chen, 2008, Targeting the p27 E3 ligase SCF(Skp2) results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy, Blood, 111, 4690, 10.1182/blood-2007-09-112904 Nickeleit, 2008, Argyrin a reveals a critical role for the tumor suppressor protein p27(kip1) in mediating antitumor activities in response to proteasome inhibition, Cancer Cell, 14, 23, 10.1016/j.ccr.2008.05.016 Rico-Bautista, 2010, Chemical genetics approach to restoring p27Kip1 reveals novel compounds with antiproliferative activity in prostate cancer cells, BMC Biol., 8, 153, 10.1186/1741-7007-8-153 Wu, 2012, Specific small molecule inhibitors of Skp2-mediated p27 degradation, Chem. Biol., 19, 1515, 10.1016/j.chembiol.2012.09.015 Yang, 2002, Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival, Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res., 8, 3419 Liu, 2009, p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function, Cancer Lett., 286, 240, 10.1016/j.canlet.2009.05.038 Koga, 2003, Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells, Hepatology, 37, 1086, 10.1053/jhep.2003.50186 Hsieh, 2012, Prodigiosin down-regulates SKP2 to induce p27(KIP1) stabilization and antiproliferation in human lung adenocarcinoma cells, Br. J. Pharmacol., 166, 2095, 10.1111/j.1476-5381.2012.01921.x Chung, 2015, Sulforaphane down-regulates SKP2 to stabilize p27(KIP1) for inducing antiproliferation in human colon adenocarcinoma cells, J. Biosci. Bioeng., 119, 35, 10.1016/j.jbiosc.2014.06.009 Sumimoto, 2006, Effective inhibition of cell growth and invasion of melanoma by combined suppression of BRAF (V599E) and Skp2 with lentiviral RNAi, Int. J. Cancer, 118, 472, 10.1002/ijc.21286 Wang, 2007, Prognostic significance of nuclear ING3 expression in human cutaneous melanoma, Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res., 13, 4111, 10.1158/1078-0432.CCR-07-0408 Chen, 2010, The tumor suppressor ING3 is degraded by SCF(Skp2)-mediated ubiquitin-proteasome system, Oncogene, 29, 1498, 10.1038/onc.2009.424 Fuchs, 2004, The many faces of beta-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer, Oncogene, 23, 2028, 10.1038/sj.onc.1207389 Perkins, 2007, Integrating cell-signalling pathways with NF-kappaB and IKK function, Nat. Rev. Mol. Cell Biol., 8, 49, 10.1038/nrm2083 Chen, 2005, Ubiquitin signalling in the NF-kappaB pathway, Nat. Cell Biol., 7, 758, 10.1038/ncb0805-758 Yaron, 1998, Identification of the receptor component of the IkappaBalpha-ubiquitin ligase, Nature, 396, 590, 10.1038/25159 Nakajima, 2008, A novel small-molecule inhibitor of NF-kappaB signaling, Biochem. Biophys. Res. Commun., 368, 1007, 10.1016/j.bbrc.2008.01.166 Nakayama, 2003, Impaired degradation of inhibitory subunit of NF-κB (IκB) and β-catenin as a result of targeted disruption of the β-TrCP1 gene, Proc. Natl. Acad. Sci., 100, 8752, 10.1073/pnas.1133216100 Yang, 2003, The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation, Mol. Cell. Biol., 23, 26, 10.1128/MCB.23.1.26-37.2003 Mudduluru, 2007, Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer, Cancer, 110, 1697, 10.1002/cncr.22983 Wei, 2009, Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer, Mol. Cancer, 8, 70, 10.1186/1476-4598-8-70 Dorrello, 2006, S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth, Science, 314, 467, 10.1126/science.1130276 Blees, 2012, Erioflorin stabilizes the tumor suppressor Pdcd4 by inhibiting its interaction with the E3-ligase beta-TrCP1, PloS ONE, 7, e46567, 10.1371/journal.pone.0046567 Peterson, 2009, DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival, Cell, 137, 873, 10.1016/j.cell.2009.03.046 Duan, 2011, mTOR generates an auto-amplification loop by triggering the betaTrCP- and CK1alpha-dependent degradation of DEPTOR, Mol. Cell, 44, 317, 10.1016/j.molcel.2011.09.005 Gao, 2011, mTOR drives its own activation via SCF(betaTrCP)-dependent degradation of the mTOR inhibitor DEPTOR, Mol. Cell, 44, 290, 10.1016/j.molcel.2011.08.030 Zhao, 2011, DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(betaTrCP) E3 ubiquitin ligase and regulates survival and autophagy, Mol. Cell, 44, 304, 10.1016/j.molcel.2011.08.029 Boyd, 2010, High expression levels of the mammalian target of rapamycin inhibitor DEPTOR are predictive of response to thalidomide in myeloma, Leuk. Lymphoma, 51, 2126, 10.3109/10428194.2010.509893 Sakamoto, 2001, Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation, Proc. Natl. Acad. Sci. U.S.A., 98, 8554, 10.1073/pnas.141230798 Sakamoto, 2003, Development of Protacs to target cancer-promoting proteins for ubiquitination and degradation, Mol. Cell. Proteomics: MCP, 2, 1350, 10.1074/mcp.T300009-MCP200 Schneekloth, 2008, Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics, Bioorgan. Med. Chem. Lett., 18, 5904, 10.1016/j.bmcl.2008.07.114 O’Connor, 1998, Bim: a novel member of the Bcl-2 family that promotes apoptosis, EMBO J., 17, 384, 10.1093/emboj/17.2.384 Fletcher, 2008, Controlling the cell death mediators Bax and Bak: puzzles and conundrums, Cell Cycle, 7, 39, 10.4161/cc.7.1.5178 Dehan, 2009, betaTrCP- and Rsk1/2-mediated degradation of BimEL inhibits apoptosis, Mol. Cell, 33, 109, 10.1016/j.molcel.2008.12.020 Rogers, 2009, The SCF Slimb ubiquitin ligase regulates Plk4/Sak levels to block centriole reduplication, J. Cell Biol., 184, 225, 10.1083/jcb.200808049 Cunha-Ferreira, 2009, The SCF/Slimb ubiquitin ligase limits centrosome amplification through degradation of SAK/PLK4, Curr. Biol.: CB, 19, 43, 10.1016/j.cub.2008.11.037 Akhoondi, 2007, FBXW7/hCDC4 is a general tumor suppressor in human cancer, Cancer Res., 67, 9006, 10.1158/0008-5472.CAN-07-1320 Spruck, 2011, miR-27a regulation of SCF(Fbw7) in cell division control and cancer, Cell Cycle, 10, 3232, 10.4161/cc.10.19.17125 Ma, 2013, Genistein down-regulates miR-223 expression in pancreatic cancer cells, Curr. Drug Targets, 14, 1150, 10.2174/13894501113149990187 Kimura, 2003, hCDC4b, a regulator of cyclin E, as a direct transcriptional target of p53, Cancer Sci., 94, 431, 10.1111/j.1349-7006.2003.tb01460.x Mao, 2004, Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene, Nature, 432, 775, 10.1038/nature03155 Balamurugan, 2010, The tumour suppressor C/EBPdelta inhibits FBXW7 expression and promotes mammary tumour metastasis, EMBO J., 29, 4106, 10.1038/emboj.2010.280 Welcker, 2004, The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation, Proc. Natl. Acad. Sci. U.S.A., 101, 9085, 10.1073/pnas.0402770101 von der Lehr, 2003, The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription, Mol. Cell, 11, 1189, 10.1016/S1097-2765(03)00193-X Kim, 2003, Skp2 regulates Myc protein stability and activity, Mol. Cell, 11, 1177, 10.1016/S1097-2765(03)00173-4 Yada, 2004, Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7, EMBO J., 23, 2116, 10.1038/sj.emboj.7600217 Zhou, 2007, Back to the future of oridonin: again, compound from medicinal herb shows potent antileukemia efficacies in vitro and in vivo, Cell Res., 17, 274, 10.1038/cr.2007.21 Huang, 2012, Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis, Mol. Cancer Ther., 11, 1155, 10.1158/1535-7163.MCT-12-0066 Xia, 2012, Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells, Curr. Drug Targets, 13, 1750, 10.2174/138945012804545597 Reavie, 2013, Regulation of c-Myc ubiquitination controls chronic myelogenous leukemia initiation and progression, Cancer Cell, 23, 362, 10.1016/j.ccr.2013.01.025 Gregory, 2000, c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells, Mol. Cell. Biol., 20, 2423, 10.1128/MCB.20.7.2423-2435.2000 Busino, 2012, Fbxw7alpha- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma, Nat. Cell Biol., 14, 375, 10.1038/ncb2463 Inoue, 2000, Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling, Exp. Cell Res., 254, 14, 10.1006/excr.1999.4733 Mallampalli, 2013, Targeting F box protein Fbxo3 to control cytokine-driven inflammation, J. Immunol., 191, 5247, 10.4049/jimmunol.1300456 Chen, 2013, Skp-cullin-F box E3 ligase component FBXL2 ubiquitinates Aurora B to inhibit tumorigenesis, Cell Death Dis., 4, e759, 10.1038/cddis.2013.271 Margolis, 2005, Tetraploidy and tumor development, Cancer Cell, 8, 353, 10.1016/j.ccr.2005.10.017 Fujiwara, 2005, Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells, Nature, 437, 1043, 10.1038/nature04217 Cimini, 2006, Aurora kinase promotes turnover of kinetochore microtubules to reduce chromosome segregation errors, Curr. Biol.: CB, 16, 1711, 10.1016/j.cub.2006.07.022 Coon, 2012, Novel E3 ligase component FBXL7 ubiquitinates and degrades Aurora A, causing mitotic arrest, Cell Cycle, 11, 721, 10.4161/cc.11.4.19171 Liu, 2015, The proapoptotic F-box protein Fbxl7 regulates mitochondrial function by mediating the ubiquitylation and proteasomal degradation of survivin, J. Biol. Chem., 290, 11843, 10.1074/jbc.M114.629931 Johansson, 2014, SCF-FBXO31 E3 ligase targets DNA replication factor Cdt1 for proteolysis in the G2 phase of cell cycle to prevent re-replication, J. Biol. Chem., 289, 18514, 10.1074/jbc.M114.559930 Santra, 2009, F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage, Nature, 459, 722, 10.1038/nature08011 Lin, 2006, Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF (FBX4-alphaB crystallin) complex, Mol. Cell, 24, 355, 10.1016/j.molcel.2006.09.007 Wade, 2013, MDM2, MDMX and p53 in oncogenesis and cancer therapy, Nat. Rev. Cancer, 13, 83, 10.1038/nrc3430 Malonia, 2015, F-box protein FBXO31 directs degradation of MDM2 to facilitate p53-mediated growth arrest following genotoxic stress, Proc. Natl. Acad. Sci. U.S.A., 112, 8632, 10.1073/pnas.1510929112 Huang, 2015, FBXO31 promotes cell proliferation, metastasis and invasion in lung cancer, Am. J. Cancer Res., 5, 1814 Liu, 2014, F-box only protein 31 (FBXO31) negatively regulates p38 mitogen-activated protein kinase (MAPK) signaling by mediating lysine 48-linked ubiquitination and degradation of mitogen-activated protein kinase kinase 6 (MKK6), J. Biol. Chem., 289, 21508, 10.1074/jbc.M114.560342 Fung, 2002, Cyclin F is degraded during G2-M by mechanisms fundamentally different from other cyclins, J. Biol. Chem., 277, 35140, 10.1074/jbc.M205503200 Nordlund, 2006, Ribonucleotide reductases, Ann. Rev. Biochem., 75, 681, 10.1146/annurev.biochem.75.103004.142443 Fu, 2013, Low cyclin F expression in hepatocellular carcinoma associates with poor differentiation and unfavorable prognosis, Cancer Sci., 104, 508, 10.1111/cas.12100 Ci, 2008, B-cell lymphoma 6 and the molecular pathogenesis of diffuse large B-cell lymphoma, Curr. Opin. Hematol., 15, 381, 10.1097/MOH.0b013e328302c7df Staudt, 2005, The biology of human lymphoid malignancies revealed by gene expression profiling, Adv. Immunol., 87, 163, 10.1016/S0065-2776(05)87005-1 Duan, 2012, FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas, Nature, 481, 90, 10.1038/nature10688 Higa, 2006, L2DTL/CDT2 interacts with the CUL4/DDB1 complex and PCNA and regulates CDT1 proteolysis in response to DNA damage, Cell Cycle, 5, 1675, 10.4161/cc.5.15.3149 Abbas, 2010, CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation, Mol. Cell, 40, 9, 10.1016/j.molcel.2010.09.014 Centore, 2010, CRL4(Cdt2)-mediated destruction of the histone methyltransferase Set8 prevents premature chromatin compaction in S phase, Mol. Cell, 40, 22, 10.1016/j.molcel.2010.09.015 Oda, 2010, Regulation of the histone H4 monomethylase PR-Set7 by CRL4(Cdt2)-mediated PCNA-dependent degradation during DNA damage, Mol. Cell, 40, 364, 10.1016/j.molcel.2010.10.011 Havens, 2011, Mechanism of CRL4(Cdt2), a PCNA-dependent E3 ubiquitin ligase, Genes Dev., 25, 1568, 10.1101/gad.2068611 Jorgensen, 2011, SET8 is degraded via PCNA-coupled CRL4(CDT2) ubiquitylation in S phase and after UV irradiation, J. Cell Biol., 192, 43, 10.1083/jcb.201009076 Hall, 2014, C/EBPalpha regulates CRL4(Cdt2)-mediated degradation of p21 in response to UVB-induced DNA damage to control the G1/S checkpoint, Cell Cycle, 13, 3602, 10.4161/15384101.2014.962957 Pan, 2006, Role of L2DTL, cell cycle-regulated nuclear and centrosome protein, in aggressive hepatocellular carcinoma, Cell Cycle, 5, 2676, 10.4161/cc.5.22.3500 Ueki, 2008, Involvement of elevated expression of multiple cell-cycle regulator DTL/RAMP (denticleless/RA-regulated nuclear matrix associated protein), in the growth of breast cancer cells, Oncogene, 27, 5672, 10.1038/onc.2008.186 Yang, 2015, The oncogenic microRNA-21 inhibits the tumor suppressive activity of FBXO11 to promote tumorigenesis, J. Biol. Chem., 290, 6037, 10.1074/jbc.M114.632125 Xue, 2015, MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity, Oncogene Dias, 2002, CUL7: A DOC domain-containing cullin selectively binds Skp1 Fbx29 to form an SCF-like complex, Proc. Natl. Acad. Sci. U.S.A., 99, 16601, 10.1073/pnas.252646399 Tsunematsu, 2006, Fbxw8 is essential for Cul1–Cul7 complex formation and for placental development, Mol. Cell. Biol., 26, 6157, 10.1128/MCB.00595-06 Okabe, 2006, A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation, PloS ONE, 1, e128, 10.1371/journal.pone.0000128 Kong, 2012, Ubiquitination and degradation of the hominoid-specific oncoprotein TBC1D3 is mediated by CUL7 E3 ligase, PloS ONE, 7, e46485, 10.1371/journal.pone.0046485 Wang, 2014, The CUL7/F-box and WD repeat domain containing 8 (CUL7/Fbxw8) ubiquitin ligase promotes degradation of hematopoietic progenitor kinase 1, J. Biol. Chem., 289, 4009, 10.1074/jbc.M113.520106 Takai, 2007, Tel2 regulates the stability of PI3K-related protein kinases, Cell, 131, 1248, 10.1016/j.cell.2007.10.052 Horejsi, 2010, CK2 phospho-dependent binding of R2TP complex to TEL2 is essential for mTOR and SMG1 stability, Mol. Cell, 39, 839, 10.1016/j.molcel.2010.08.037 Takai, 2010, Tel2 structure and function in the Hsp90-dependent maturation of mTOR and ATR complexes, Genes Dev., 24, 2019, 10.1101/gad.1956410 Kaizuka, 2010, Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly, J. Biol. Chem., 285, 20109, 10.1074/jbc.M110.121699 Fernandez-Saiz, 2013, SCFFbxo9 and CK2 direct the cellular response to growth factor withdrawal via Tel2/Tti1 degradation and promote survival in multiple myeloma, Nat. Cell Biol., 15, 72, 10.1038/ncb2651 Kim, 2013, CRL4A-FBXW5-mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth, Proc. Natl. Acad. Sci. U.S.A., 110, 16868, 10.1073/pnas.1306358110 Hsu, 2002, E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APCCdh1, Nat. Cell Biol., 4, 358, 10.1038/ncb785 Gutgemann, 2008, Emi1 protein accumulation implicates misregulation of the anaphase promoting complex/cyclosome pathway in ovarian clear cell carcinoma, Mod. Pathol., 21, 445, 10.1038/modpathol.3801022 Huang, 2011, 1,2,3,4,6-penta-O-galloyl-beta-d-glucose, quercetin, curcumin and lycopene induce cell-cycle arrest in MDA-MB-231 and BT474 cells through downregulation of Skp2 protein, J. Agric. Food Chem., 59, 6765, 10.1021/jf201096v Huang, 2008, EGCG stabilizes p27kip1 in E2-stimulated MCF-7 cells through down-regulation of the Skp2 protein, Endocrinology, 149, 5972, 10.1210/en.2008-0408 Yang, 2003, Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm, J. Biol. Chem., 278, 46862, 10.1074/jbc.M306340200 Gao, 2014, Nuclear retention of Fbw7 by specific inhibitors of nuclear export leads to Notch1 degradation in pancreatic cancer, Oncotarget, 5, 3444, 10.18632/oncotarget.1813 Huang, 2012, Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis, Mol. Cancer Ther., 11, 1155, 10.1158/1535-7163.MCT-12-0066 Nangle, 2013, Crystal structure of mammalian cryptochrome in complex with a small molecule competitor of its ubiquitin ligase, Cell Res., 23, 1417, 10.1038/cr.2013.136 Hirota, 2012, Identification of small molecule activators of cryptochrome, Science, 337, 1094, 10.1126/science.1223710 Lagarou, 2008, dKDM2 couples histone H2A ubiquitylation to histone H3 demethylation during Polycomb group silencing, Genes Dev., 22, 2799, 10.1101/gad.484208 Tzatsos, 2013, KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs, J. Clin. Invest., 123, 727 Xiao, 2015, FBXL20-mediated Vps34 ubiquitination as a p53 controlled checkpoint in regulating autophagy and receptor degradation, Genes Dev., 29, 184, 10.1101/gad.252528.114 Takagi, 2012, SCRAPPER Regulates the Thresholds of Long-Term Potentiation/Depression, the Bidirectional Synaptic Plasticity in Hippocampal CA3-CA1 Synapses, Neural Plast., 2012, 7, 10.1155/2012/352829 Dobie, 2007, A fight for neurotransmission: SCRAPPER trashes RIM, Cell, 130, 775, 10.1016/j.cell.2007.08.020 Yao, 2007, SCRAPPER-dependent ubiquitination of active zone protein RIM1 regulates synaptic vesicle release, Cell, 130, 943, 10.1016/j.cell.2007.06.052 Zhu, 2012, Role of FBXL20 in human colorectal adenocarcinoma, Oncol. Rep., 28, 2290, 10.3892/or.2012.2065 Zhu, 2014, FBXL20 acts as an invasion inducer and mediates E-cadherin in colorectal adenocarcinoma, Oncol. Lett., 7, 2185, 10.3892/ol.2014.2031 Huber, 2005, Identification of mutations in CUL7 in 3-M syndrome, Nat. Genet., 37, 1119, 10.1038/ng1628 Ponyeam, 2012, Characterization of the Cullin7 E3 ubiquitin ligase – heterodimerization of cullin substrate receptors as a novel mechanism to regulate cullin E3 ligase activity, Cell. Signal., 24, 290, 10.1016/j.cellsig.2011.08.020 Okabe, 2006, A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation, PloS ONE, 1, e128, 10.1371/journal.pone.0000128 Xu, 2008, The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation, Mol. Cell, 30, 403, 10.1016/j.molcel.2008.03.009 Litterman, 2011, An OBSL1-Cul7Fbxw8 ubiquitin ligase signaling mechanism regulates golgi morphology and dendrite patterning, PLoS Biol., 9, e1001060, 10.1371/journal.pbio.1001060 Barbash, 2008, Mutations in Fbx4 inhibit dimerization of the SCFFbx4 ligase and contribute to cyclin D1 overexpression in human cancer, Cancer Cell, 14, 68, 10.1016/j.ccr.2008.05.017 Lin, 2006, Phosphorylation-dependent ubiquitination of cyclin D1 by the SCFFBX4-αB crystallin complex, Mol. Cell, 24, 355, 10.1016/j.molcel.2006.09.007 Koepp, 2001, Phosphorylation-dependent ubiquitination of cyctin E by the SCFFbw7 ubiquitin ligase, Science, 294, 173, 10.1126/science.1065203 Lee, 2006, The F-box protein FBX4 targets PIN2/TRF1 for ubiquitin-mediated degradation and regulates telomere maintenance, J. Biol. Chem., 281, 759, 10.1074/jbc.M509855200 Chen, 2011, Bcr-Abl-induced tyrosine phosphorylation of Emi1 to stabilize Skp2 protein via inhibition of ubiquitination in chronic myeloid leukemia cells, J. Cell. Physiol., 226, 407, 10.1002/jcp.22346 Lehman, 2007, Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors, Am. J. Pathol., 170, 1793, 10.2353/ajpath.2007.060767 Fernández-Sáiz, 2013, SCFFbxo9 and CK2 direct the cellular response to growth factor withdrawal via Tel2/Tti1 degradation and promote survival in multiple myeloma, Nat. Cell Biol., 15, 72, 10.1038/ncb2651 Smits, 2012, An insulator loop resides between the synthetically interacting elements of the human/rat conserved breast cancer susceptibility locus MCS5A/Mcs5a, Nucleic Acids Res., 40, 132, 10.1093/nar/gkr610 Xu, 2014, Human MCS5A1 candidate breast cancer susceptibility gene FBXO10 is induced by cellular stress and correlated with lens epithelium-derived growth factor (LEDGF), Mol. Carcinog., 53, 300, 10.1002/mc.21977 Samuelson, 2007, Rat Mcs5a is a compound quantitative trait locus with orthologous human loci that associate with breast cancer risk, Proc. Natl. Acad. Sci., 104, 6299, 10.1073/pnas.0701687104 Zheng, 2014, PKD1 phosphorylation-dependent degradation of SNAIL by SCF-FBXO11 regulates epithelial-mesenchymal transition and metastasis, Cancer Cell, 26, 358, 10.1016/j.ccr.2014.07.022 Jeong, 2013, FBH1 protects melanocytes from transformation and is deregulated in melanomas, Cell Cycle, 12, 1128, 10.4161/cc.24165 Jeong, 2013, FBH1 promotes DNA double-strand breakage and apoptosis in response to DNA replication stress, J. Cell Biol., 200, 141, 10.1083/jcb.201209002 Fugger, 2009, Human Fbh1 helicase contributes to genome maintenance via pro- and anti-recombinase activities, J. Cell Biol., 186, 655, 10.1083/jcb.200812138 Huang, 2010, FBXO31 is down-regulated and may function as a tumor suppressor in hepatocellular carcinoma, Oncol. Rep., 24, 715 Kogo, 2011, FBXO31 determines poor prognosis in esophageal squamous cell carcinoma, Int. J. Oncol., 39, 155